NEW YORK (Oct. 14, 2008) -- In the last decade, biomedical and research breakthroughs, notably in genetics and stem cells, have helped transform the care of children, improving diagnosis and treatment for numerous diseases. On Nov. 8 and 9, Morgan Stanley Children's Hospital of NewYork-Presbyterian and Columbia University Medical Center will host a conference at the Grand Hyatt New York, titled "Innovations in Pediatric Medicine," to exchange the latest advances in genetics, stem cell therapy, and childhood disease treatment.
The continuing medical education (CME) conference will feature lectures by international leading authorities in pediatric care in congenital and primary immunodeficiencies, gene therapy in children, the genetic basis for common childhood infections and a rational approach to pediatric emergency care during unplanned national or regional disasters.
"Medical breakthroughs have greatly increased the range of treatment options for pediatric diseases, which is why we are thrilled to bring together medical professionals who are on the frontline of pediatric care for this opportunity of learning the latest progress and the sharing of best practices," says the conference's course director, Dr. Mitchell Cairo, director of pediatric blood and marrow transplantation at Morgan Stanley Children's Hospital of NewYork-Presbyterian and professor of pediatrics, medicine and pathology at Columbia University College of Physicians and Surgeons.
A brief listing of speakers and topics is below. For the complete two-day conference program, visit: www.nyp.org/pdf/innovations_cme_schedule.pdf.
Saturday, Nov. 8
Bench to Bedside Genetics: A Pediatrician's Viewpoint
Dr. Gerald M. Loughlin, Phyllis and David Komansky Center for Children's Health at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and Wei
|Contact: Belinda Mager|
New York- Presbyterian Hospital/Columbia University Medical Center